Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hangzhou Zhicheng Technology is a biotechnology company specializing in microfluidic technology and high-throughput single-cell analysis solutions. The company develops automated systems for single-cell droplet generation, microfluidic chips, and specialized reagents for genomics and proteomics research. Their core technology enables precise single-cell sequencing and functional analysis at scale, facilitating breakthroughs in oncology research, immunology, and drug discovery. Zhicheng Technology serves a broad range of clients, including academic institutions, clinical laboratories, and pharmaceutical companies. By integrating advanced microfluidics with biological applications, the company provides essential tools for the advancement of precision medicine.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 杭州志呈科技.